Total Funding
87
75
Total FundingPost-IPO Debt raised
Growth Score
-2 pts
Heat Score
6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
38598
ENCell is a biotechnology company focused on advanced biopharmaceutical manufacturing and therapeutic development.
About the Company
ENCell is an advanced biopharmaceutical company specializing in cell and gene therapy (CGT) contract development and manufacturing (CDMO), contract quality testing, and the development of novel stem cell and gene therapies for rare and incurable diseases. The company operates multiple GMP facilities and provides integrated development,
manufacturing, testing, and regulatory support services.
